Children's Hepatic International Collaboration (CHIC) is renowned for developing the well-known PRETEXT risk stratification, utilizing factors such as the age of onset, tumor invasion extent, AFP level and metastatic status, etc. (80). This evidence concerns the gene AFP and neoplasm.